Outlook Therapeutics, Inc.

OTLK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015
Assets
Cash & Equivalents $3.2M $2.4M $9.1M
Accounts Receivable — — $20.0K
Inventory — — —
Total Current Assets $3.9M $5.7M $15.2M
Property, Plant & Equipment $16.1M $18.7M $17.8M
Goodwill — — —
Intangible Assets (Excl. Goodwill) — — —
Total Assets $20.7M $25.4M $35.0M
Liabilities
Accounts Payable $11.0M $5.1M $11.6M
Total Current Liabilities $28.7M $20.4M $37.0M
Long-Term Debt $151.1K $2.2M $2.9M
Total Liabilities $51.5M $30.6M $62.6M
Stockholders' Equity
Retained Earnings $-186.2M $-147.4M $-94.1M
Total Stockholders' Equity $-33.7M $-5.2M $-54.2M
← Newer Page 2 of 2 Older →